PDB Short entry for 4YMJ HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-MAR-15 4YMJ TITLE (R)-2-PHENYLPYRROLIDINE SUBSTITUTE IMIDAZOPYRIDAZINES: A NEW CLASS OF TITLE 2 POTENT AND SELECTIVE PAN-TRK INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: NT-3 GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GP145-TRKC,TRK-C,NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE COMPND 5 3,TRKC TYROSINE KINASE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: SEQUENCE REFERS TO NTRK3 ISOFORM B PRECURSOR COMPND 9 (NP_002521.2) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NTRK3, TRKC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: [FASTBACT-HM KEYWDS KINASE, TRK, INHIBITOR, ONCOLOGY, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.KREUSCH,P.RUCKER,V.MOLTENI,J.LOREN REVDAT 2 27-SEP-23 4YMJ 1 SOURCE REMARK REVDAT 1 03-JUN-15 4YMJ 0 JRNL AUTH H.S.CHOI,P.V.RUCKER,Z.WANG,Y.FAN,P.ALBAUGH,G.CHOPIUK, JRNL AUTH 2 F.GESSIER,F.SUN,F.ADRIAN,G.LIU,T.HOOD,N.LI,Y.JIA,J.CHE, JRNL AUTH 3 S.MCCORMACK,A.LI,J.LI,A.STEFFY,A.CULAZZO,C.TOMPKINS,V.PHUNG, JRNL AUTH 4 A.KREUSCH,M.LU,B.HU,A.CHAUDHARY,M.PRASHAD,T.TUNTLAND,B.LIU, JRNL AUTH 5 J.HARRIS,H.M.SEIDEL,J.LOREN,V.MOLTENI JRNL TITL (R)-2-PHENYLPYRROLIDINE SUBSTITUTED IMIDAZOPYRIDAZINES: A JRNL TITL 2 NEW CLASS OF POTENT AND SELECTIVE PAN-TRK INHIBITORS. JRNL REF ACS MED.CHEM.LETT. V. 6 562 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26005534 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00050 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.9_1692) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.70 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.980 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.2 REMARK 3 NUMBER OF REFLECTIONS : 49818 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 2479 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.7176 - 5.2396 0.86 2579 148 0.1859 0.1887 REMARK 3 2 5.2396 - 4.1596 0.89 2687 124 0.1362 0.1742 REMARK 3 3 4.1596 - 3.6340 0.89 2678 134 0.1448 0.1675 REMARK 3 4 3.6340 - 3.3018 0.90 2693 155 0.1424 0.1805 REMARK 3 5 3.3018 - 3.0652 0.90 2702 146 0.1655 0.2239 REMARK 3 6 3.0652 - 2.8845 0.88 2623 154 0.1702 0.1970 REMARK 3 7 2.8845 - 2.7401 0.90 2692 172 0.1686 0.2267 REMARK 3 8 2.7401 - 2.6208 0.88 2691 123 0.1728 0.1954 REMARK 3 9 2.6208 - 2.5199 0.89 2632 135 0.1768 0.2004 REMARK 3 10 2.5199 - 2.4330 0.87 2667 122 0.1747 0.2200 REMARK 3 11 2.4330 - 2.3569 0.89 2725 114 0.1677 0.2036 REMARK 3 12 2.3569 - 2.2895 0.83 2542 136 0.1721 0.2180 REMARK 3 13 2.2895 - 2.2293 0.89 2668 143 0.1822 0.2239 REMARK 3 14 2.2293 - 2.1749 0.88 2620 147 0.1865 0.2318 REMARK 3 15 2.1749 - 2.1254 0.85 2567 142 0.1952 0.2648 REMARK 3 16 2.1254 - 2.0802 0.88 2692 129 0.1970 0.2593 REMARK 3 17 2.0802 - 2.0386 0.84 2512 127 0.1964 0.2205 REMARK 3 18 2.0386 - 2.0001 0.78 2369 128 0.2237 0.2589 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.560 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4570 REMARK 3 ANGLE : 1.024 6177 REMARK 3 CHIRALITY : 0.045 666 REMARK 3 PLANARITY : 0.005 828 REMARK 3 DIHEDRAL : 15.577 1710 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -5.5380 -9.0101 11.0436 REMARK 3 T TENSOR REMARK 3 T11: 0.2840 T22: 0.1870 REMARK 3 T33: 0.2071 T12: -0.0015 REMARK 3 T13: -0.0208 T23: -0.0228 REMARK 3 L TENSOR REMARK 3 L11: 1.2424 L22: 0.0957 REMARK 3 L33: 0.2432 L12: -0.1548 REMARK 3 L13: 0.2480 L23: -0.0399 REMARK 3 S TENSOR REMARK 3 S11: -0.0180 S12: -0.0214 S13: -0.0300 REMARK 3 S21: 0.0100 S22: -0.0123 S23: -0.0068 REMARK 3 S31: 0.0373 S32: -0.0016 S33: 0.0162 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YMJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1000207707. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49818 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.920 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.73000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3V5Q REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5 M NACL, 0.1 M NA/K PHOSPHATE PH REMARK 280 6.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 117.08133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 58.54067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -8 REMARK 465 ALA A -7 REMARK 465 MET A -6 REMARK 465 GLY A -5 REMARK 465 SER A -4 REMARK 465 ASP A 635 REMARK 465 ALA A 636 REMARK 465 MET A 637 REMARK 465 ILE A 638 REMARK 465 LEU A 639 REMARK 465 VAL A 640 REMARK 465 ASP A 641 REMARK 465 GLY A 642 REMARK 465 GLN A 643 REMARK 465 PRO A 644 REMARK 465 ARG A 645 REMARK 465 GLN A 646 REMARK 465 ALA A 647 REMARK 465 LYS A 648 REMARK 465 MET A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 VAL A 726 REMARK 465 GLY A 727 REMARK 465 GLY A 728 REMARK 465 PRO A 832 REMARK 465 ILE A 833 REMARK 465 TYR A 834 REMARK 465 LEU A 835 REMARK 465 ASP A 836 REMARK 465 ILE A 837 REMARK 465 LEU A 838 REMARK 465 GLY A 839 REMARK 465 GLY B -8 REMARK 465 ALA B -7 REMARK 465 MET B -6 REMARK 465 GLY B -5 REMARK 465 SER B -4 REMARK 465 ASP B 611 REMARK 465 ASP B 635 REMARK 465 ALA B 636 REMARK 465 MET B 637 REMARK 465 ILE B 638 REMARK 465 LEU B 639 REMARK 465 VAL B 640 REMARK 465 ASP B 641 REMARK 465 GLY B 642 REMARK 465 GLN B 643 REMARK 465 PRO B 644 REMARK 465 ARG B 645 REMARK 465 GLN B 646 REMARK 465 ALA B 647 REMARK 465 LYS B 648 REMARK 465 VAL B 726 REMARK 465 GLY B 727 REMARK 465 GLY B 728 REMARK 465 LEU B 835 REMARK 465 ASP B 836 REMARK 465 ILE B 837 REMARK 465 LEU B 838 REMARK 465 GLY B 839 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 549 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 564 CG CD CE NZ REMARK 470 LYS A 575 CG CD CE NZ REMARK 470 ASP A 576 CG OD1 OD2 REMARK 470 LEU A 579 CG CD1 CD2 REMARK 470 LYS A 583 CG CD CE NZ REMARK 470 ARG A 587 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 611 CG OD1 OD2 REMARK 470 ARG A 711 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 729 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 768 CG CD CE NZ REMARK 470 PHE B 549 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 575 CG CD CE NZ REMARK 470 ASP B 576 CG OD1 OD2 REMARK 470 LEU B 579 CG CD1 CD2 REMARK 470 LYS B 583 CG CD CE NZ REMARK 470 GLU B 588 CG CD OE1 OE2 REMARK 470 MET B 700 CG SD CE REMARK 470 ARG B 711 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 729 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 790 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 1182 O HOH B 1185 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O ARG A 536 O HOH B 1001 2444 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 542 144.84 -171.09 REMARK 500 THR A 563 -93.74 -84.18 REMARK 500 ASP A 576 74.34 35.85 REMARK 500 ARG A 678 -12.83 78.41 REMARK 500 ASP A 679 46.54 -142.37 REMARK 500 LYS B 564 148.18 -172.63 REMARK 500 ASP B 576 72.49 35.54 REMARK 500 ARG B 678 -14.15 78.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4EJ A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 905 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4EJ B 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 904 DBREF 4YMJ A 530 839 UNP Q16288 NTRK3_HUMAN 522 817 DBREF 4YMJ B 530 839 UNP Q16288 NTRK3_HUMAN 522 817 SEQADV 4YMJ GLY A -8 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ ALA A -7 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ MET A -6 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ GLY A -5 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ SER A -4 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ GLY A -3 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ ILE A -2 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ HIS A -1 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ GLY B -8 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ ALA B -7 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ MET B -6 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ GLY B -5 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ SER B -4 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ GLY B -3 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ ILE B -2 UNP Q16288 EXPRESSION TAG SEQADV 4YMJ HIS B -1 UNP Q16288 EXPRESSION TAG SEQRES 1 A 304 GLY ALA MET GLY SER GLY ILE HIS VAL GLN HIS ILE LYS SEQRES 2 A 304 ARG ARG ASP ILE VAL LEU LYS ARG GLU LEU GLY GLU GLY SEQRES 3 A 304 ALA PHE GLY LYS VAL PHE LEU ALA GLU CYS TYR ASN LEU SEQRES 4 A 304 SER PRO THR LYS ASP LYS MET LEU VAL ALA VAL LYS ALA SEQRES 5 A 304 LEU LYS ASP PRO THR LEU ALA ALA ARG LYS ASP PHE GLN SEQRES 6 A 304 ARG GLU ALA GLU LEU LEU THR ASN LEU GLN HIS GLU HIS SEQRES 7 A 304 ILE VAL LYS PHE TYR GLY VAL CYS GLY ASP GLY ASP PRO SEQRES 8 A 304 LEU ILE MET VAL PHE GLU TYR MET LYS HIS GLY ASP LEU SEQRES 9 A 304 ASN LYS PHE LEU ARG ALA HIS GLY PRO ASP ALA MET ILE SEQRES 10 A 304 LEU VAL ASP GLY GLN PRO ARG GLN ALA LYS GLY GLU LEU SEQRES 11 A 304 GLY LEU SER GLN MET LEU HIS ILE ALA SER GLN ILE ALA SEQRES 12 A 304 SER GLY MET VAL TYR LEU ALA SER GLN HIS PHE VAL HIS SEQRES 13 A 304 ARG ASP LEU ALA THR ARG ASN CYS LEU VAL GLY ALA ASN SEQRES 14 A 304 LEU LEU VAL LYS ILE GLY ASP PHE GLY MET SER ARG ASP SEQRES 15 A 304 VAL TYR SEP THR ASP TYR TYR ARG VAL GLY GLY HIS THR SEQRES 16 A 304 MET LEU PRO ILE ARG TRP MET PRO PRO GLU SER ILE MET SEQRES 17 A 304 TYR ARG LYS PHE THR THR GLU SER ASP VAL TRP SER PHE SEQRES 18 A 304 GLY VAL ILE LEU TRP GLU ILE PHE THR TYR GLY LYS GLN SEQRES 19 A 304 PRO TRP PHE GLN LEU SER ASN THR GLU VAL ILE GLU CYS SEQRES 20 A 304 ILE THR GLN GLY ARG VAL LEU GLU ARG PRO ARG VAL CYS SEQRES 21 A 304 PRO LYS GLU VAL TYR ASP VAL MET LEU GLY CYS TRP GLN SEQRES 22 A 304 ARG GLU PRO GLN GLN ARG LEU ASN ILE LYS GLU ILE TYR SEQRES 23 A 304 LYS ILE LEU HIS ALA LEU GLY LYS ALA THR PRO ILE TYR SEQRES 24 A 304 LEU ASP ILE LEU GLY SEQRES 1 B 304 GLY ALA MET GLY SER GLY ILE HIS VAL GLN HIS ILE LYS SEQRES 2 B 304 ARG ARG ASP ILE VAL LEU LYS ARG GLU LEU GLY GLU GLY SEQRES 3 B 304 ALA PHE GLY LYS VAL PHE LEU ALA GLU CYS TYR ASN LEU SEQRES 4 B 304 SER PRO THR LYS ASP LYS MET LEU VAL ALA VAL LYS ALA SEQRES 5 B 304 LEU LYS ASP PRO THR LEU ALA ALA ARG LYS ASP PHE GLN SEQRES 6 B 304 ARG GLU ALA GLU LEU LEU THR ASN LEU GLN HIS GLU HIS SEQRES 7 B 304 ILE VAL LYS PHE TYR GLY VAL CYS GLY ASP GLY ASP PRO SEQRES 8 B 304 LEU ILE MET VAL PHE GLU TYR MET LYS HIS GLY ASP LEU SEQRES 9 B 304 ASN LYS PHE LEU ARG ALA HIS GLY PRO ASP ALA MET ILE SEQRES 10 B 304 LEU VAL ASP GLY GLN PRO ARG GLN ALA LYS GLY GLU LEU SEQRES 11 B 304 GLY LEU SER GLN MET LEU HIS ILE ALA SER GLN ILE ALA SEQRES 12 B 304 SER GLY MET VAL TYR LEU ALA SER GLN HIS PHE VAL HIS SEQRES 13 B 304 ARG ASP LEU ALA THR ARG ASN CYS LEU VAL GLY ALA ASN SEQRES 14 B 304 LEU LEU VAL LYS ILE GLY ASP PHE GLY MET SER ARG ASP SEQRES 15 B 304 VAL TYR SEP THR ASP TYR TYR ARG VAL GLY GLY HIS THR SEQRES 16 B 304 MET LEU PRO ILE ARG TRP MET PRO PRO GLU SER ILE MET SEQRES 17 B 304 TYR ARG LYS PHE THR THR GLU SER ASP VAL TRP SER PHE SEQRES 18 B 304 GLY VAL ILE LEU TRP GLU ILE PHE THR TYR GLY LYS GLN SEQRES 19 B 304 PRO TRP PHE GLN LEU SER ASN THR GLU VAL ILE GLU CYS SEQRES 20 B 304 ILE THR GLN GLY ARG VAL LEU GLU ARG PRO ARG VAL CYS SEQRES 21 B 304 PRO LYS GLU VAL TYR ASP VAL MET LEU GLY CYS TRP GLN SEQRES 22 B 304 ARG GLU PRO GLN GLN ARG LEU ASN ILE LYS GLU ILE TYR SEQRES 23 B 304 LYS ILE LEU HIS ALA LEU GLY LYS ALA THR PRO ILE TYR SEQRES 24 B 304 LEU ASP ILE LEU GLY MODRES 4YMJ SEP A 706 SER MODIFIED RESIDUE MODRES 4YMJ SEP B 706 SER MODIFIED RESIDUE HET SEP A 706 10 HET SEP B 706 10 HET 4EJ A 901 40 HET GOL A 902 6 HET GOL A 903 6 HET GOL A 904 6 HET CL A 905 1 HET 4EJ B 901 40 HET GOL B 902 6 HET GOL B 903 6 HET GOL B 904 6 HETNAM SEP PHOSPHOSERINE HETNAM 4EJ 4-[6-(BENZYLAMINO)IMIDAZO[1,2-B]PYRIDAZIN-3- HETNAM 2 4EJ YL]BENZONITRILE HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETSYN SEP PHOSPHONOSERINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 4EJ 2(C20 H15 N5) FORMUL 4 GOL 6(C3 H8 O3) FORMUL 7 CL CL 1- FORMUL 12 HOH *383(H2 O) HELIX 1 AA1 LYS A 534 ARG A 536 5 3 HELIX 2 AA2 THR A 578 LEU A 595 1 18 HELIX 3 AA3 ASP A 624 HIS A 632 1 9 HELIX 4 AA4 GLY A 652 GLN A 673 1 22 HELIX 5 AA5 ALA A 681 ARG A 683 5 3 HELIX 6 AA6 ALA A 689 LEU A 691 5 3 HELIX 7 AA7 TYR A 705 TYR A 709 5 5 HELIX 8 AA8 PRO A 733 MET A 737 5 5 HELIX 9 AA9 PRO A 738 ARG A 745 1 8 HELIX 10 AB1 THR A 748 THR A 765 1 18 HELIX 11 AB2 SER A 775 GLN A 785 1 11 HELIX 12 AB3 PRO A 796 TRP A 807 1 12 HELIX 13 AB4 GLU A 810 ARG A 814 5 5 HELIX 14 AB5 ASN A 816 THR A 831 1 16 HELIX 15 AB6 LYS B 534 ARG B 536 5 3 HELIX 16 AB7 THR B 578 LEU B 595 1 18 HELIX 17 AB8 ASP B 624 ALA B 631 1 8 HELIX 18 AB9 GLY B 652 GLN B 673 1 22 HELIX 19 AC1 ALA B 681 ARG B 683 5 3 HELIX 20 AC2 ALA B 689 LEU B 691 5 3 HELIX 21 AC3 MET B 700 TYR B 705 1 6 HELIX 22 AC4 SEP B 706 TYR B 709 5 4 HELIX 23 AC5 PRO B 733 MET B 737 5 5 HELIX 24 AC6 PRO B 738 ARG B 745 1 8 HELIX 25 AC7 THR B 748 THR B 765 1 18 HELIX 26 AC8 SER B 775 GLN B 785 1 11 HELIX 27 AC9 PRO B 796 TRP B 807 1 12 HELIX 28 AD1 GLU B 810 ARG B 814 5 5 HELIX 29 AD2 ASN B 816 THR B 831 1 16 SHEET 1 AA1 6 HIS A 532 ILE A 533 0 SHEET 2 AA1 6 PHE A 603 CYS A 607 1 O VAL A 606 N ILE A 533 SHEET 3 AA1 6 ILE A 614 GLU A 618 -1 O VAL A 616 N TYR A 604 SHEET 4 AA1 6 LYS A 566 LEU A 574 -1 N ALA A 570 O PHE A 617 SHEET 5 AA1 6 GLY A 550 TYR A 558 -1 N PHE A 553 O VAL A 571 SHEET 6 AA1 6 ILE A 538 GLU A 546 -1 N ARG A 542 O LEU A 554 SHEET 1 AA2 2 CYS A 685 VAL A 687 0 SHEET 2 AA2 2 VAL A 693 ILE A 695 -1 O LYS A 694 N LEU A 686 SHEET 1 AA3 6 HIS B 532 ILE B 533 0 SHEET 2 AA3 6 PHE B 603 CYS B 607 1 O VAL B 606 N ILE B 533 SHEET 3 AA3 6 ILE B 614 GLU B 618 -1 O VAL B 616 N TYR B 604 SHEET 4 AA3 6 LYS B 566 LEU B 574 -1 N ALA B 570 O PHE B 617 SHEET 5 AA3 6 GLY B 550 TYR B 558 -1 N PHE B 553 O VAL B 571 SHEET 6 AA3 6 ILE B 538 GLU B 546 -1 N ARG B 542 O LEU B 554 SHEET 1 AA4 2 CYS B 685 VAL B 687 0 SHEET 2 AA4 2 VAL B 693 ILE B 695 -1 O LYS B 694 N LEU B 686 LINK C TYR A 705 N SEP A 706 1555 1555 1.33 LINK C SEP A 706 N THR A 707 1555 1555 1.33 LINK C TYR B 705 N SEP B 706 1555 1555 1.32 LINK C SEP B 706 N THR B 707 1555 1555 1.33 CISPEP 1 ASP A 611 PRO A 612 0 -2.76 CISPEP 2 THR B 831 PRO B 832 0 -5.77 SITE 1 AC1 11 GLY A 545 VAL A 552 ALA A 570 LYS A 572 SITE 2 AC1 11 PHE A 617 GLU A 618 TYR A 619 MET A 620 SITE 3 AC1 11 LEU A 686 PHE A 698 GOL A 902 SITE 1 AC2 9 LYS A 572 GLU A 588 LEU A 592 PHE A 617 SITE 2 AC2 9 GLY A 696 ASP A 697 PHE A 698 4EJ A 901 SITE 3 AC2 9 GOL A 903 SITE 1 AC3 4 ILE A 695 GLY A 696 ASP A 697 GOL A 902 SITE 1 AC4 10 ARG A 735 TRP A 754 TRP A 771 CYS A 782 SITE 2 AC4 10 ILE A 783 ARG A 787 VAL A 788 LEU A 789 SITE 3 AC4 10 TRP A 807 HOH A1067 SITE 1 AC5 6 ARG A 535 ILE A 538 LEU A 540 ARG B 535 SITE 2 AC5 6 ILE B 538 LEU B 540 SITE 1 AC6 13 VAL B 552 ALA B 570 LYS B 572 PHE B 617 SITE 2 AC6 13 GLU B 618 TYR B 619 MET B 620 GLY B 623 SITE 3 AC6 13 LEU B 686 PHE B 698 MET B 700 GOL B 902 SITE 4 AC6 13 HOH B1048 SITE 1 AC7 6 LYS B 572 GLY B 696 ASP B 697 PHE B 698 SITE 2 AC7 6 4EJ B 901 GOL B 904 SITE 1 AC8 6 HIS B 599 HIS B 658 GLN B 662 ASN B 690 SITE 2 AC8 6 LEU B 691 LEU B 692 SITE 1 AC9 7 ILE B 600 PHE B 675 ILE B 695 GLY B 696 SITE 2 AC9 7 ASP B 697 GOL B 902 HOH B1122 CRYST1 65.610 65.610 175.622 90.00 90.00 120.00 P 32 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015242 0.008800 0.000000 0.00000 SCALE2 0.000000 0.017599 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005694 0.00000